Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 8 September 2022
Accepted: 8 December 2022
First Online: 26 December 2022
Declarations
:
: Not applicable.
: Not applicable.
: Claudio Soto is a Founder, Chief Scientific Officer, and Member of the Board of Directors of Amprion Inc., a biotechnology company that focuses on the commercial use of PMCA for high-sensitivity detection of misfolded protein aggregates implicated in various neurodegenerative diseases. Sandra Pritzkow also has a conflict of interest with Amprion. The University of Texas Health Science Center at Houston has licensed patents and patent applications to Amprion.
